NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 68 filers reported holding NEOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $45,000 | -66.2% | 27,500 | 0.0% | 0.02% | -60.0% |
Q3 2018 | $133,000 | -22.7% | 27,500 | 0.0% | 0.06% | -32.1% |
Q2 2018 | $172,000 | -24.6% | 27,500 | 0.0% | 0.08% | -27.0% |
Q1 2018 | $228,000 | -18.9% | 27,500 | 0.0% | 0.11% | -26.5% |
Q4 2017 | $281,000 | +11.5% | 27,500 | 0.0% | 0.15% | -3.2% |
Q3 2017 | $252,000 | -83.6% | 27,500 | -86.9% | 0.16% | -85.7% |
Q2 2017 | $1,532,000 | +123.3% | 209,873 | +120.3% | 1.09% | +88.4% |
Q1 2017 | $686,000 | +202.2% | 95,273 | +145.1% | 0.58% | +191.5% |
Q4 2016 | $227,000 | -11.3% | 38,873 | 0.0% | 0.20% | +11.8% |
Q3 2016 | $256,000 | -29.1% | 38,873 | 0.0% | 0.18% | -37.8% |
Q2 2016 | $361,000 | -13.8% | 38,873 | 0.0% | 0.29% | -20.8% |
Q1 2016 | $419,000 | -53.9% | 38,873 | -38.7% | 0.36% | -55.4% |
Q4 2015 | $908,000 | -31.8% | 63,400 | 0.0% | 0.81% | -38.8% |
Q3 2015 | $1,332,000 | – | 63,400 | – | 1.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|